Anti-Small leucine rich protein 1 antibody
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Polyclonal Small leucine rich protein 1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human SMLR1 aa 50 to C-terminus.
View Alternative Names
Small leucine-rich protein 1, SMLR1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Small leucine rich protein 1 antibody (AB204982)
Immunohistochemical analysis of paraffin-embedded Human urinary bladder tissue labeling Small leucine rich protein 1 with ab204982 at 1/50 dilution.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Small leucine rich proteins such as SLRP1 are involved in the regulation of collagen fibrillogenesis. They interact directly with collagen fibrils and influence fiber size and spacing. SLRP1 is also known to impact cellular proliferation and differentiation which is partly due to its interaction with various growth factor receptors. This protein does not commonly form part of large stable complexes but may transiently associate with other extracellular matrix components during tissue development and repair.
Pathways
Several studies link small leucine rich proteins including SLRP1 to the transforming growth factor-beta (TGF-β) signaling pathway. TGF-β is important for controlling cell growth and repair mechanisms and SLRP1 can modulate its activity by influencing its bioavailability and receptor interactions. Additionally SLRP1 may have roles in the Wnt signaling pathway connected through indirect mechanisms related to extracellular matrix stability further interacting with other structural proteins in extracellular environments.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Clinical epigenetics 12:173 PubMed33203470
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com